Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

Keyphrases

• Protein Kinase Inhibitors 100%
• Glioblastoma multiforme 100%
• Glioblastoma multiforme Cells 100%
• Induced Neurons 80%
• MTOR Inhibitor 60%
• Tumorigenicity 40%
• Local Recurrence 40%
• Pluripotent Stem Cells 20%
• Receptor-mediated 20%
• Clinical Trials 20%
• Action Potential 20%
• Mammalian Target of Rapamycin (mTOR) 20%
• Novel Therapeutics 20%
• Cancer Cells 20%
• Defined Factors 20%
• Cancer Treatment 20%
• Primary Brain Tumor 20%
• Neuronal Cells 20%
• Combined Modality Therapy 20%
• Neurotransmitter Receptors 20%
• Kinase Inhibitor 20%
• Anticancer Drugs 20%
• Transcriptional Analysis 20%
• Innovative Strategies 20%
• Proliferation Ability 20%
• Reprogramming Methods 20%
• Neuronal Proteins 20%
• ROCK Inhibitor 20%
• In Vivo Tumorigenesis 20%
• Kinase Inhibitor Design 20%
• Reprogramming Strategies 20%
• ROCK Kinase 20%

Biochemistry, Genetics and Molecular Biology

• Reprogramming 100%
• Protein Kinases 100%
• Mammalian Target of Rapamycin 66%
• Stem Cell 16%
• Cancer Cell 16%
• Clinical Trial 16%
• Kinase 16%
• Phosphotransferase 16%
• Carcinogenesis 16%
• Protein Kinase A 16%
• Action Potential 16%
• Cell Reprogramming Technique 16%
• Neurotransmitter Receptor 16%

Neuroscience

• Reprogramming 100%
• Glioblastoma Multiforme 100%
• Protein Kinase Inhibitor 100%
• Action Potential 11%
• In Vivo 11%
• Protein 11%
• In Vitro 11%
• Kinase 11%
• Stem Cell 11%
• Carcinogenesis 11%
• Protein Kinase A 11%
• Neurotransmitter Receptor 11%
• Intracranial Tumor 11%